Health inequalities included in updated cancer referral guidelines The Scottish government's ‘Cancer Strategy for Scotland 2023–2033’ highlights that there is “convincing evidence” that socioeconomic and health disparities are linked with increased diagnoses of more advanced cancers.…
Government advises chief pharmacists to coordinate aid between trusts amid radioisotope shortage According to a national patient safety alert issued on 25 October 2024, the radioisotope shortage stems from a combination of technical issues and essential maintenance work.…
NICE overturns decision on blood cancer treatment elranatamab Elranatamab is now recommended as a fourth-line treatment for relapsed and refractory multiple myeloma, according to updated guidance from the National Institute for Health and Care Excellence.…
NICE lifts restrictions on myeloma treatment teclistamab in final draft guidance The updated guidance recommends the monoclonal antibody for anyone with relapsed or refractory multiple myeloma who has received three or more lines of treatment and whose myeloma has progressed.…
Pharmacy teams identify patients with ‘red-flag’ cancer symptoms in early diagnosis project Exclusive: Of those identified, 17 people presenting with red-flag symptoms received a formal consultation with a pharmacist during the six-month project.…
Cancer Research UK offers training to Tesco pharmacists to spot possible cancer symptoms Tesco pharmacists have also been trained to offer advice by the British Heart Foundation and Diabetes UK.…
How can pharmacists best support patients with chronic lymphocytic leukaemia? As therapies for chronic lymphocytic leukaemia have evolved, so has pharmacists’ role in treating people with this type of blood cancer.… Supported content
MHRA approves capivasertib for treatment of advanced breast cancer Capivasertib is an oral pill given with fulvestrant, a hormonal therapy, as an alternative treatment to endocrine-based regimens.…
Draft NICE guidance recommends ‘at-home’ pill for advance prostate cancer The National institute of Health and Care Excellence says up to 40,000 people in England could benefit from relugolix (Orgovyx; Accord).…
How AI is transforming drug discovery Pharmaceutical companies and start-ups are harnessing AI to improve speed and reduce costs at every stage of the drug discovery and development process.…
